Advisory Research’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-277,449
Closed -$20.4M 311
2019
Q3
$20.4M Sell
277,449
-9,208
-3% -$668K 0.98% 38
2019
Q2
$20.5M Sell
286,657
-431
-0.2% -$30.6K 0.4% 68
2019
Q1
$19.7M Buy
287,088
+21,108
+8% +$1.36M 0.38% 71
2018
Q4
$15.8M Buy
+265,980
New +$16.6M 0.34% 83
2016
Q3
Sell
-5,894
Closed -$431K 259
2016
Q2
$431K Sell
5,894
-86
-1% -$6.12K 0.01% 215
2016
Q1
$422K Sell
5,980
-227
-4% -$15.1K 0.01% 224
2015
Q4
$414K Sell
6,207
-1,528
-20% -$102K 0.01% 244
2015
Q3
$491K Sell
7,735
-1,262
-14% -$82.4K 0.01% 251
2015
Q2
$588K Sell
8,997
-5,989
-40% -$406K 0.01% 273
2015
Q1
$1.04M Buy
14,986
+593
+4% +$41K 0.01% 238
2014
Q4
$996K Sell
14,393
-593
-4% -$40K 0.01% 253
2014
Q3
$977K Buy
14,986
+357
+2% +$23.5K 0.01% 253
2014
Q2
$997K Sell
14,629
-3,163
-18% -$212K 0.01% 251
2014
Q1
$1.15M Buy
17,792
+3,813
+27% +$240K 0.01% 225
2013
Q4
$912K Sell
13,979
-1,163
-8% -$74.4K 0.01% 247
2013
Q3
$898K Buy
15,142
+1,138
+8% +$67.4K 0.01% 245
2013
Q2
$802K Buy
+14,004
New +$831K 0.01% 254

Other funds holding CL

Advisory Research's CL Position: Q4 2019 in Review

Advisory Research sold out of Colgate-Palmolive (CL) in Q4 2019, closing a stake of 277,449 shares — an estimated $20.4M sold.

Advisory Research first reported a position in CL in Q2 2013 and held it in 17 quarters. The position peaked at $20.5M in Q2 2019. 1,509 funds tracked by Wall St. Rank hold CL as of Q4 2019.

  • Advisory Research reported no remaining Colgate-Palmolive position as of Q4 2019 after selling out during the quarter.
  • Advisory Research sold 277,449 Colgate-Palmolive shares in Q4 2019, an estimated $20.4M.
  • Advisory Research first reported a position in Colgate-Palmolive in Q2 2013 and held it in 17 quarters.
  • Advisory Research's Colgate-Palmolive position peaked at $20.5M in Q2 2019.
  • 1,509 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2019.

Based on Advisory Research's 13F filing for Q4 2019, filed 11 Feb 2020.